Evidence map›Paper›PMID 26503035›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2015

Secondhand Tobacco Smoke Exposure and Lung Adenocarcinoma In Situ/Minimally Invasive Adenocarcinoma (AIS/MIA).

Claire H Kim, Yuan-Chin Amy Lee, Rayjean J Hung, Paolo Boffetta, Dong Xie, Jason A Wampfler, Michele L Cote, Shen-Chih Chang, Donatella Ugolini, Monica Neri and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Quality of the patient-oriented web-based information on esophageal cancer.Journal of cancer education : the official journal of the American Association for Cancer Education · 2022
    Article
  6. Article
  7. Review
  8. Global Epidemiology of Lung Cancer.Annals of global health · 2019
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 4 countries.

Claire H KimDepartment of Epidemiology, Fielding School of Public Health, University of California at Los Angeles (UCLA), Los Angeles, California.
Yuan-Chin Amy LeeDepartment of Family and Preventive Medicine, University of Utah, Salt Lake City, Utah.
Rayjean J HungLunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada.
Paolo BoffettaThe Tisch Cancer Institute and Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, New York.
Dong XieDepartment of Thoracic Surgery, ShangHai Pulmonary Hospital, ShangHai, China. Mayo Clinic Cancer Center, Rochester, Minnesota.
Jason A WampflerMayo Clinic Cancer Center, Rochester, Minnesota.
Michele L CoteKarmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan.
Shen-Chih ChangDepartment of Epidemiology, Fielding School of Public Health, University of California at Los Angeles (UCLA), Los Angeles, California.
Donatella UgoliniInternal Medicine, University of Genoa, Genoa, Italy. Unit of Epidemiology, Biostatistics, and Clinical Trials, IRCSS Azienda Ospedaliera Universitaria San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy.
Monica NeriClinical and Molecular Epidemiology, IRCCS San Raffaele Pisana, Rome, Italy.
Loic Le MarchandCancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii.
Ann G SchwartzKarmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan.
Hal MorgensternDepartments of Epidemiology and Environmental Health Sciences, School of Public Health, and Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan.
David C ChristianiDepartment of Environmental Health, Harvard University School of Public Health, Boston, Massachusetts.
Ping YangMayo Clinic Cancer Center, Rochester, Minnesota.
Zuo-Feng ZhangDepartment of Epidemiology, Fielding School of Public Health, University of California at Los Angeles (UCLA), Los Angeles, California. zfzhang@ucla.edu.
Cancer Clinic · USUniversity of California, Los Angeles · USThe Barbara Ann Karmanos Cancer Institute · USAlleanza Contro il Cancro · ITBoston University · USCancer Center of Hawaii · USLunenfeld-Tanenbaum Research Institute · CATisch Hospital · USUniversity of Michigan · USUniversity of Utah · USVita-Salute San Raffaele University · IT

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI PAUL M STEMMER · 1985 to 2026
$68.4M
UCLA SPORE IN LUNG CANCERP50CA090388 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2001 to 2008
$13.0M
Translational studies of Hsp90 inhibitors in NSCLCP50CA090578 · NCI · DANA-FARBER CANCER INST · PI MEYERSON, MATTHEW L. · 2008 to 2012
$11.4M
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer ResearchR35CA197449 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI XIHONG LIN · 2015 to 2026
$10.9M
UCLA CANCER EPIDEMIOLOGY TRAINING PROGRAMT32CA009142 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZHANG, ZUO-FENG · 1986 to 2024
$6.3M
GENETIC EPIDEMIOLOGY OF LUNG CANCERR01CA060691 · NCI · WAYNE STATE UNIVERSITY · PI SCHWARTZ, ANN G. · 1995 to 2009
$6.2M
Molecular and Genetic Analysis of Lung Cancer SurvivalR01CA092824 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 2002 to 2013
$5.9M
SPORE in Lung CancerP20CA090578 · NCI · DANA-FARBER CANCER INSTITUTE · PI JOHNSON, BRUCE E. · 2003 to 2007
$5.1M
GENETIC SUSCEPTIBILITY TO LUNG CANCERR01CA074386 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 1997 to 2008
$4.8M
ALPHA 1 AD CARRIERS AND LUNG CANCER RISKR01CA080127 · NCI · MAYO CLINIC ROCHESTER · PI YANG, PING · 2000 to 2009
$4.4M
Genetic Determinants of Lung Cancer SurvivalR01CA084354 · NCI · MAYO CLINIC ROCHESTER · PI YANG, PING · 2001 to 2012
$4.0M
Adenocarinoma of the Lung in WomenR01CA087895 · NCI · WAYNE STATE UNIVERSITY · PI SCHWARTZ, ANN G · 2001 to 2005
$3.0M
NCI NIH HHS CA084354NCI NIH HHS CA090578NCI NIH HHS CA09142NCI NIH HHS CA092824NCI NIH HHS CA115857NCI NIH HHS CA74386NCI NIH HHS CA80127NCI NIH HHS CA90833NCI NIH HHS K07 CA125203NCI NIH HHS K07CA125203NCI NIH HHS N01 PC035145NCI NIH HHS N01-PC35145NCI NIH HHS P20 CA090578NCI NIH HHS P30 CA022453NCI NIH HHS P30CA22453NCI NIH HHS P50 CA090388NCI NIH HHS P50 CA090578NCI NIH HHS R01 CA060691NCI NIH HHS R01CA060691NCI NIH HHS R01 CA074386NCI NIH HHS R01 CA080127NCI NIH HHS R01 CA084354NCI NIH HHS R01 CA087895NCI NIH HHS R01 CA090833NCI NIH HHS R01 CA092824NCI NIH HHS R01 CA115857NCI NIH HHS R01CA 55874NCI NIH HHS R01CA87895NCI NIH HHS R03 CA077118NCI NIH HHS R35 CA197449NCI NIH HHS T32 CA009142NIDA NIH HHS DA11386NIDA NIH HHS R01 DA011386NIEHS NIH HHS ES011667NIEHS NIH HHS R21 ES011667
6 · The paper itself

Abstract

The aim of this study was to estimate the effect of exposure to secondhand tobacco smoke on the incidence of lung adenocarcinoma in situ/minimally invasive adenocarcinoma (AIS/MIA). Data from seven case-control studies participating in the International Lung Cancer Consortium (ILCCO) were pooled, resulting in 625 cases of AIS/MIA and 7,403 controls, of whom 170 cases and 3,035 controls were never smokers. Unconditional logistic regression was used to estimate adjusted ORs (ORadj) and 95% confidence intervals (CI), controlling for age, sex, race, smoking status (ever/never), and pack-years of smoking. Study center was included in the models as a random-effects intercept term. Ever versus never exposure to secondhand tobacco smoke was positively associated with AIS/MIA incidence in all subjects (ORadj = 1.48; 95% CI, 1.14-1.93) and in never smokers (ORadj = 1.45; 95% CI, 1.00-2.12). There was, however, appreciable heterogeneity of ORadj across studies (P = 0.01), and the pooled estimates were largely influenced by one large study (40% of all cases and 30% of all controls). These findings provide weak evidence for an effect of secondhand tobacco smoke exposure on AIS/MIA incidence. Further studies are needed to assess the impact of secondhand tobacco smoke exposure using the newly recommended classification of subtypes of lung adenocarcinoma.

Indexed as

AdenocarcinomaAdenocarcinoma of LungAgedAged, 80 and overCase-Control StudiesFemaleHumansLung NeoplasmsMaleMiddle AgedRisk FactorsTobacco Smoke PollutionTobacco Smoke Pollution

Identifiers

PMID26503035
PMCPMC4734370
OpenAlexW1881225908

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.